Response to anticoagulant therapy in patients with cancer depends on the tumor
A study by the RIETE Group shows that a daily injection is associated with less severe bleeding and lower mortality Cancer is one of the risk factors of venous thromboembolic disease (VTE). As well, both thrombosis and pulmonary embolism are very frequent in...
Cancer and anticoagulant treatment, focus of the 12th VTE Forum
One out of three patients with VTE does not receive the appropriate dose More than 350 medical specialists attended the 12th Venous Thromboembolism (VTE) Forum that was held in Cuenca last week. Professionals of different VTE-related medical specialties presented new...
Warfarine is safe after first therapy with low molecular weight heparin in patients with cancer and thrombosis
Cancer patients who develop thrombosis and/or pulmonary embolism can replace their daily injections of low molecular weight heparin with a warfarin pill after the first six months of treatment. That’s what a study done by Dr. Chatree Chai-Adisaksopha, of McMaster...